Our study demonstrates that Nar, a bioactive flavonoid derived from citrus, may exert therapeutic effects on MASLD through a multi-target and multi-pathway mechanism. This evidence concerns the gene CPSF4 and metabolic dysfunction-associated steatotic liver disease.